1. Home
  2. MUX vs ALDX Comparison

MUX vs ALDX Comparison

Compare MUX & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$19.31

Market Cap

936.8M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.95

Market Cap

293.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
ALDX
Founded
1979
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
936.8M
293.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MUX
ALDX
Price
$19.31
$4.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$21.63
$9.50
AVG Volume (30 Days)
1.2M
1.6M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$166,453,000.00
N/A
Revenue This Year
$7.70
N/A
Revenue Next Year
$29.02
$36.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$1.14
52 Week High
$24.88
$7.20

Technical Indicators

Market Signals
Indicator
MUX
ALDX
Relative Strength Index (RSI) 57.32 49.88
Support Level $18.65 $3.94
Resistance Level $20.03 $5.68
Average True Range (ATR) 1.07 0.42
MACD 0.04 0.03
Stochastic Oscillator 56.41 57.93

Price Performance

Historical Comparison
MUX
ALDX

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: